GlaxoSmithKline S.A.E
GlaxoSmithKline S.A.E. (GSK) is a leading global healthcare company headquartered in Great Britain. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has established a strong presence in pharmaceuticals, vaccines, and consumer healthcare. The company operates extensively across Europe, North America, and emerging markets, focusing on innovative solutions to improve patient health. GSK's core products include prescription medicines, vaccines, and over-the-counter health products, distinguished by their commitment to research and development. Notable achievements include advancements in respiratory and HIV treatments, positioning GSK as a key player in the global pharmaceutical landscape. With a robust pipeline and a dedication to sustainability, GSK continues to drive progress in the healthcare industry.
DitchCarbon Score
How does GlaxoSmithKline S.A.E's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline S.A.E's score of 59 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline S.A.E's reported carbon emissions
GlaxoSmithKline S.A.E, headquartered in Great Britain, currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company is expected to align with industry standards and best practices in addressing climate change. As part of the pharmaceutical sector, GSK is likely to engage in initiatives aimed at reducing carbon footprints and enhancing sustainability. Future disclosures may provide insights into their strategies and progress in mitigating climate-related risks.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline S.A.E is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
